Aimee J. Li

Array ( [id] => 11568920 [patent_doc_number] => 20170107565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'FUNCTIONALIZED PARTICLES FOR LABEL-FREE DNA IMPEDIMETRIC BIOSENSOR FOR DNA AND RNA SENSING' [patent_app_type] => utility [patent_app_number] => 15/297776 [patent_app_country] => US [patent_app_date] => 2016-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11383244 [patent_doc_number] => 20170009301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'METHOD FOR DIAGNOSING HEMATOLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/278353 [patent_app_country] => US [patent_app_date] => 2016-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22602 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15278353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13444989 [patent_doc_number] => 20180274037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => NOVEL BIOMARKERS FOR PANCREATIC DISEASES [patent_app_type] => utility [patent_app_number] => 15/762275 [patent_app_country] => US [patent_app_date] => 2016-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17792560 [patent_doc_number] => 20220251651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => METHODS OF CHARACTERIZING RESISTANCE TO MODULATORS OF CEREBLON [patent_app_type] => utility [patent_app_number] => 15/759159 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13397465 [patent_doc_number] => 20180250275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => MODIFIERS OF CFTR-DIRECTED THERAPY [patent_app_type] => utility [patent_app_number] => 15/756791 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -95 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12909862 [patent_doc_number] => 20180195130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => Methods for Molecularly Characterizing Cervical Cell Samples [patent_app_type] => utility [patent_app_number] => 15/741891 [patent_app_country] => US [patent_app_date] => 2016-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13623011 [patent_doc_number] => 20180363057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => METHOD FOR EVALUATING INDIVIDUAL RADIOSENSITIVITY AND THE RISK OF ADVERSE EFFECTS [patent_app_type] => utility [patent_app_number] => 15/755249 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675849 [patent_doc_number] => 20160376658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF ALCOHOLISM [patent_app_type] => utility [patent_app_number] => 15/243682 [patent_app_country] => US [patent_app_date] => 2016-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37808 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13372617 [patent_doc_number] => 20180237849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => RNA MAPPING/FINGERPRINTING [patent_app_type] => utility [patent_app_number] => 15/753297 [patent_app_country] => US [patent_app_date] => 2016-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11402028 [patent_doc_number] => 20170022566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS' [patent_app_type] => utility [patent_app_number] => 15/222218 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16641 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11715231 [patent_doc_number] => 20170183730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/217885 [patent_app_country] => US [patent_app_date] => 2016-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20583 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15217885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13343593 [patent_doc_number] => 20180223336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => GENETIC TESTING FOR PREDICTING RESISTANCE OF MORGANELLA SPECIES AGAINST ANTIMICROBIAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/745935 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13871549 [patent_doc_number] => 20190032115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => GENETIC TESTING FOR PREDICTING RESISTANCE OF GRAM-NEGATIVE PROTEUS AGAINST ANTIMICROBIAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/745253 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14072979 [patent_doc_number] => 20190085377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => GENETIC TESTING FOR PREDICTING RESISTANCE OF SALMONELLA SPECIES AGAINST ANTIMICROBIAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/745330 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21114 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13428741 [patent_doc_number] => 20180265913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => GENETIC TESTING FOR PREDICTING RESISTANCE OF PSEUDOMONAS SPECIES AGAINST ANTIMICROBIAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/745633 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364436 [patent_doc_number] => 20170002418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS' [patent_app_type] => utility [patent_app_number] => 15/212581 [patent_app_country] => US [patent_app_date] => 2016-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10430 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15212581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11395533 [patent_doc_number] => 20170016069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'METHOD FOR TESTING FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND METHOD FOR SCREENING AGENT FOR TREATMENT OF THE DISEASE' [patent_app_type] => utility [patent_app_number] => 15/211131 [patent_app_country] => US [patent_app_date] => 2016-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12748 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15211131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675867 [patent_doc_number] => 20160376667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => QUALITY CONTROL OF AGRICULTURAL PRODUCTS BASED ON GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 15/200376 [patent_app_country] => US [patent_app_date] => 2016-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25620 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364437 [patent_doc_number] => 20170002417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING ALTERED EFFECTIVENESS OF BETA BLOCKER THERAPY' [patent_app_type] => utility [patent_app_number] => 15/198473 [patent_app_country] => US [patent_app_date] => 2016-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20950 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107984 [patent_doc_number] => 20160304955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'IN VITRO METHOD FOR SCREENING FOR CANDIDATE COMPOUNDS FOR PREVENTING AND/OR ATTENUATING AGEING OF THE SKIN, AND/OR FOR HYDRATING THE SKIN' [patent_app_type] => utility [patent_app_number] => 15/196393 [patent_app_country] => US [patent_app_date] => 2016-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8400 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15196393 [rel_patent_id] =>[rel_patent_doc_number] =>)